IT major Infosys said on Monday that it will acquire Simplus in an up to $250 million deal.

The group has more than 243 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003...

Ranbaxy has received necessary regulatory approvals from the Spanish health authorities to manufacture and market Olanzapine in Spain.

Apart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...

Sales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...